Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elsa Briones"'
Autor:
Sara Casáis Muñoz, Isabel Peña Pérez, María Victoria Poncela García, Raúl Martínez de Arriba, Elsa Briones Cuesta, María Dolores Badía Carnicero, Sandra Delgado Cuesta
Publikováno v:
Revista del Laboratorio Clínico. 10:14-20
Resumen Introduccion La terapia con anticuerpos monoclonales desarrollada en los ultimos anos se utiliza actualmente en numerosas patologias. Al ser similares estructuralmente a las inmunoglobulinas endogenas podrian detectarse como bandas monoclonal
Autor:
Dominique Detaille, Elsa Briones, José M. López-Novoa, Xavier Leverve, Mohamad-Yehia El-Mir, Marta Prieto, Miguel Arévalo, Angel Puente, Ana I. Morales
Publikováno v:
Kidney International
Kidney International, Nature Publishing Group, 2010, 77 (10), pp.861-9. ⟨10.1038/ki.2010.11⟩
Kidney International, Nature Publishing Group, 2010, 77 (10), pp.861-9. ⟨10.1038/ki.2010.11⟩
International audience; The antidiabetic drug metformin can diminish apoptosis induced by oxidative stress in endothelial cells and prevent vascular dysfunction even in nondiabetic patients. Here we tested whether it has a beneficial effect in a rat
Publikováno v:
International journal of pharmaceutics. 401(1-2)
Antiretroviral-loaded erythrocytes offer a promising therapy against HIV owing to their potential to deliver this kind of drugs to macrophages and reticulo-endothelial (RES) tissues. The aim of the present work was to develop and optimize a hypotonic
Autor:
Elsa Briones Cuesta
Publikováno v:
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
instname
[EN] The first objective of this study was to perform a complete review about the problems in the treatment of intracellular infections. It also reflects the different types of delivery systems currently available and the benefits they bring in the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e96bb19efba21cf0441824d528806863
https://hdl.handle.net/10366/76416
https://hdl.handle.net/10366/76416
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 125(3)
Many infectious diseases are caused by facultative organisms that are able to survive in phagocytic cells. The intracellular location of these microorganisms protects them from the host defence systems and from some antibiotics with poor penetration
Publikováno v:
Journal of drug targeting. 15(1)
In the last years, different non-biological and biological carrier systems have been developed for anti-HIV1 therapy. Liposomes are excellent potential anti-HIV1 carriers that have been tested with drugs, antisense oligonucleotides, ribozymes and the